ArticleMolecular diversity2026
Exploring anti-dengue activity with atomic-weighted vectors, class balancing and machine learning.
Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue is a major mosquito-borne viral disease with no effective antiviral treatment currently available. This work introduces a machine-learning framework to predict anti-dengue activity in small molecules using Atomic-Weighted Vector (AWV) descriptors and data-balancing techniques. Sixteen datasets, each containing 2118 molecules, were generated with MD-LOVIs (Molecular Descriptor from Local Vertex Invariants) and preprocessed with IMMAN (Information theory-based CheMoMetric ANalysis), with Shannon entropy applied for feature selection. To address class imbalance (imbalance ratio = 6.66), the ADASYN algorithm was employed. Thirty classifiers spanning six methodological families were evaluated under two validation schemes (tenfold cross-validation and percentage split) on both balanced and imbalanced datasets. Performance was assessed using accuracy (ACC). Nonparametric statistical tests (Friedman, Nemenyi, Wilcoxon) indicated that data balancing improved model robustness. Tree-based and function-based classifiers achieved the best predictive performance. Overall, the proposed workflow offers a reproducible, data-driven approach for virtual screening of anti-dengue compounds and is readily extensible to other antiviral drug discovery tasks.
Indexed as
Identifiers
42105140What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.